全球生物醫學加溫解凍設備市場規模、佔有率、成長分析、依產品（手動、自動）、依樣本（血液製品、卵子/胚胎）-產業預測 2024-2031

Global Biomedical Warming and Thawing Devices Market Size, Share, Growth Analysis, By Product(Manual, Automatic), By Sample(Blood Products, Ovum/Embryo) - Industry Forecast 2024-2031

出版日期: 2024年05月02日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，全球生物醫學加溫解凍設備市場規模為3.75億美元，預計將從2023年的4.0785億美元成長到2031年的7.9846億美元，預測期間（2024-2031年）複合年成長率為8.76億美元，預測期內（2024-2031年）複合年成長率為8.76億美元，預測期（2024-2031） % 。

近年來，全球生物醫學加溫和解凍設備市場見證了顯著的成長和發展。這些設備透過促進冷凍生物樣本的受控解凍和升溫，在各種生物醫學和生命科學應用中發揮至關重要的作用，包括細胞培養、體外受精 (IVF)、藥物發現和生物庫。市場成長的一個重要推動因素是對再生醫學和生物銀行研究的需求不斷成長。隨著再生醫學領域的不斷擴大，對用於移植的冷凍保存細胞和組織的精確、高效解凍和加溫的需求日益成長。儲存各種生物樣本的生物樣本庫也依賴這些設備在檢索過程中保持樣本的完整性。此外，COVID-19 大流行凸顯了這些設備在疫苗、血液製品和診斷試劑儲存和運輸中的重要性，進一步促進了其市場擴張。技術進步促進了創新自動化加溫和解凍設備的發展，這些設備可提高解凍過程的精度和速度。這些設備還具有方便用戶使用的介面和可自訂的設置，使它們對研究人員和臨床醫生更具吸引力。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2023 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率 (%), 2023

主要公司簡介

Helmer Scientific, Inc. (USA)
Thermo Fisher Scientific Inc. (USA)
Sarstedt AG & Co. KG (Germany)
Boekel Scientific (USA)
Barkey GmbH & Co. KG (Germany)
BioCision, LLC (USA)
Cardinal Health, Inc. (USA)
Sartorius AG (Germany)
Biocool (France)
Helago-Celsis (Germany)
CytoTherm (USA)
Cole-Parmer Instrument Company, LLC (USA)
Cyagen Biosciences (USA)
Geno Technology, Inc. (USA)
BrainBits LLC (USA)
ADVANCED BIOLOGICAL MARKETING (USA)
Hamilton Bonaduz AG (Switzerland)
Deltalab SL (Spain)
Boehringer Ingelheim (Germany)
Arlington Scientific, Inc. (USA)
Hamilton Company (USA)
GE Healthcare (USA)
ThawSTAR (USA)
3M (USA)
Thomas Scientific (USA)

簡介目錄

Product Code: SQMIG35B2178

Global biomedical warming and thawing devices market size was valued at USD 375 million in 2022 and is poised to grow from USD 407.85 million in 2023 to USD 798.46 million by 2031, growing at a CAGR of 8.76% in the forecast period (2024-2031).

The global biomedical warming and thawing devices market has witnessed remarkable growth and evolution in recent years. These devices play a crucial role in various biomedical and life science applications, including cell culture, in vitro fertilization (IVF), drug discovery, and biobanking, by facilitating controlled thawing and warming of frozen biological samples. A significant driver of market growth is the increasing demand for regenerative medicine and biobanking research. With the expanding field of regenerative medicine, there is a growing need for precise and efficient thawing and warming of cryopreserved cells and tissues for transplantation. Biobanks, which store a wide array of biological samples, also rely on these devices to maintain sample integrity during retrieval. Additionally, the COVID-19 pandemic has underscored the importance of these devices in the storage and transportation of vaccines, blood products, and diagnostic reagents, further contributing to their market expansion. Technological advancements have led to the development of innovative and automated warming and thawing devices that offer enhanced precision and speed in the thawing process. These devices also feature user-friendly interfaces and customizable settings, making them more appealing to researchers and clinicians.

Top-down and bottom-up approaches were used to estimate and validate the size of the global biomedical warming and thawing devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomedical Warming and Thawing Devices Market Segmental Analysis

The global biomedical warming and thawing devices market is segmented based on product, sample, end consumer, and place. By Product, the market is segmented into manual, and automatic. By sample, the market is segmented into Blood products, ovum/embryo, semen, and others. By end person, the market is segmented into hospitals, research laboratories, pharmaceutical industry, blood banks and transfusion centers, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Biomedical Warming and Thawing Devices Market

The increasing demand for biopharmaceutical products, including vaccines, antibodies, and cell-based therapies, has heightened the requirement for efficient and specialized warming and thawing devices. These devices play a crucial role in the safe and effective storage and processing of biopharmaceuticals, thus driving market growth.

Restraints in the Global Biomedical Warming and Thawing Devices Market

Biomedical warming and thawing devices can come with a hefty price tag for both purchase and installation. The substantial initial capital investment needed for these devices can pose a significant barrier, particularly for smaller healthcare facilities, research laboratories, and developing nations. This cost factor has the potential to limit market adoption.

Market Trends of the Global Biomedical Warming and Thawing Devices Market

One notable trend in the biomedical warming and thawing devices market is the increasing adoption of automated thawing solutions. Traditional thawing methods, such as manual water bath thawing, can be time-consuming and pose the risk of sample contamination. Automated thawing devices offer precision and efficiency in thawing various types of samples, including blood products, cellular therapies, and frozen tissues. These devices often feature advanced temperature control and monitoring capabilities, ensuring the preservation of sample integrity. The demand for automated thawing solutions is expected to continue rising as laboratories and healthcare facilities seek to streamline their sample preparation processes and reduce the risk of human errors.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Biomedical Warming and Thawing Devices Market By Product

Market Overview
Manual
Automatic

Global Biomedical Warming and Thawing Devices Market By Sample

Market Overview
Blood Products
Ovum/Embryo
Semen
and Others

Global Biomedical Warming and Thawing Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Helmer Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sarstedt AG & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boekel Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Barkey GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioCision, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocool (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helago-Celsis (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CytoTherm (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cole-Parmer Instrument Company, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyagen Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Geno Technology, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BrainBits LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ADVANCED BIOLOGICAL MARKETING (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Bonaduz AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Deltalab S.L. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arlington Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ThawSTAR (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thomas Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments